Beta 2-microglobulin expression of AIDS-related and classical Kaposi's sarcoma

APMIS. 1995 Jul-Aug;103(7-8):553-7. doi: 10.1111/j.1699-0463.1995.tb01405.x.

Abstract

The expression of beta 2-microglobulin, the invariable light chain of HLA class I molecules, of Kaposi's sarcoma from 11 AIDS patients and from 11 patients without known immunodeficiency was studied by immunohistochemistry using a polyclonal antibody to beta 2-microglobulin. The staining intensity of spindle cells in these lesions was scored in a semiquantitative system. We found that the spindle cells of Kaposi's sarcomas from AIDS patients showed significantly increased staining intensity for beta 2-microglobulin compared to those of Kaposi's sarcomas from non-AIDS patients. The results may indicate that Kaposi's sarcomas developing in immunocompromised individuals, such as AIDS patients, are not subject to immune selection by T cells eliminating HLA class I high-expressing tumor cells, while this may be the case in non-AIDS patients. Alternatively, the results may be caused by differences in the activity of cytokines, which upregulate the expression of HLA class I molecules on the cell surface.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / metabolism*
  • Acquired Immunodeficiency Syndrome / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sarcoma, Kaposi / complications
  • Sarcoma, Kaposi / metabolism*
  • Sarcoma, Kaposi / pathology
  • Skin Neoplasms / complications
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / pathology
  • beta 2-Microglobulin / biosynthesis*

Substances

  • beta 2-Microglobulin